knowledge -WSS

knowledge

author：knowledge 2025-10-01 15:29:24 - browse：4894

Dolly sheep — Alex Hogan/STAT, Getty Images

Dolly, the first animal to be cloned from an adult of its species, was born 20 years ago today at the Roslin Institute in Scotland. When her creators announced what they had done, it triggered warnings of rich people cloning themselves for spare parts, of tyrants cloning soldiers for armies, of bereaved parents cloning their dead child to produce a replacement — and promises that the technique would bring medical breakthroughs. Which raises some questions:

Why are there no human clones?

Because of scientific, ethical, and commercial reasons.

The scientists who created Dolly — named after Dolly Parton, naturally — removed the DNA from a sheep ovum, fused the ovum with a mammary epithelial cell from an adult “donor” sheep, and transplanted the result, now carrying DNA only from the donor, into a surrogate ewe. But that technique, called somatic cell nuclear transfer (SCNT), turned out not to be so easy in other species.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Test for long Covid? Researchers find new clue in blood samples

explore

WSS

The surgeon had a dilemma only a Nazi medical text could resolve

ARCH Venture Partners is raising $3 billion for a life sciences fund

Parkinson’s finding may lead to tests and, someday, treatments

Dewpoint Therapeutics lays off staff after losing partnerships

Eli Lilly, Pfizer, and others want in on the online prescription market

The lessons of Aduhelm, an Alzheimer's drug that was not to be

explore

knowledge

Why are there no human clones?

focus

Tori Bowie and the unacceptable rates of Black maternal death

New brain studies show LSD's effects on the brain in full color

Jerome Adams on the need for new antivirals for Covid

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Medical records are filled with copy

General Catalyst, Summa Health deal will turn on physician buy

Novavax promises a turnaround & Lilly roils the obesity market

Vertex non

In age of alternative facts, a scholarly course on calling out crap

Biotech venture capitalists face new demands from investors

entertainment

AI generated plenty of interest at JPM but not a lot of trust

Quicker fix for pulse oximeters urged during FDA public meeting

Covid misinformation case heads to Supreme Court

Why doctors need education on FDA device approval process

Eli Lilly, Pfizer, and others want in on the online prescription market

What we need to know about Arena Bioworks

knowledge

hotspot

explore

entertainment